A new community approach to treat opioid use disorder and prevent HIV.
Community-Based Opioid Treatment (CBOT): Development and testing of a novel nurse-led model to delivery opioid use disorder treatment and HIV prevention and care in the community setting.
This study is looking at a new way to help people with opioid use disorder and prevent HIV by bringing care right into the community, using friendly nurses and outreach workers to support those at high risk with medication and services that can really make a difference in their health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11168537 on NIH RePORTER |
What this research studies
This research focuses on developing and testing a community-based model for treating opioid use disorder (OUD) and providing HIV prevention and care. It aims to improve retention in treatment by utilizing nurse care managers and community outreach workers to deliver services directly to individuals at high risk. The approach includes the use of buprenorphine, a medication proven to reduce overdose risk and improve HIV care outcomes. By bringing these services into the community, the research seeks to engage more people in care and enhance their health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who use opioids and are at risk for HIV infection or have HIV.
Not a fit: Patients who do not use opioids or are not at risk for HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve access to and retention in treatment for individuals with opioid use disorder and those at risk for HIV.
How similar studies have performed: Previous research has shown success with community-based approaches to healthcare delivery, particularly in improving access to treatment for substance use disorders.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Heidari, Omeid — University of Washington
- Study coordinator: Heidari, Omeid
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.